EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer

被引：976

作者：

Adrian P. Bracken ^{[1
]}

Diego Pasini ^{[1
]}

Maria Capra ^{[1
]}

Elena Prosperini ^{[2
]}

Elena Colli ^{[1
]}

Kristian Helin ^{[1
]}

机构：

[1] European Institute of Oncology, Department of Experimental Oncology, 20141 Milan

[2] FIRC Institute of Molecular Oncology, 20139 Milan

来源：

The EMBO Journal | 2003年 / 22卷 / 20期

关键词：

E2F; EED; EZH2; Polycomb; pRB;

D O I：

10.1093/emboj/cdg542

中图分类号：

学科分类号：

摘要：

Recent experiments have demonstrated that the Polycomb group (PcG) gene EZH2 is highly expressed in metastatic prostate cancer and in lymphomas. EZH2 is a component of the PRC2 histone methyltransferase complex, which also contains EED and SUZ12 and is required for the silencing of HOX gene expression during embryonic development. Here we demonstrate that both EZH2 and EED are essential for the proliferation of both transformed and non-transformed human cells. In addition, the pRB-E2F pathway tightly regulates their expression and, consistent with this, we find that EZH2 is highly expressed in a large set of human tumors. These results raise the question whether EZH2 is a marker of proliferation or if it is actually contributing to tumor formation. Significantly, we propose that EZH2 is a bona fide oncogene, since we find that ectopic expression of EZH2 is capable of providing a proliferative advantage to primary cells and, in addition, its gene locus is specifically amplified in several primary tumors.

引用

页码：5323 / 5335

页数：12

共 41 条

[1] Andersen C.L., Et al., High-throughput copy number analysis of 17q23 in 3520 tissue specimens by fluorescence in situ hybridization to tissue microarrays, Am. J. Pathol., 161, pp. 73-79, (2002)
[2] Beier R., Et al., Induction of cyclin E-cdk2 kinase activity. E2F-dependent transcription and cell growth by Myc are genetically separable events, EMBO J., 19, pp. 5813-5823, (2000)
[3] Brock H.W., Van Lohuizen M., The Polycomb group - No longer an exclusive club?, Curr. Opin. Genet. Dev., 11, pp. 175-181, (2001)
[4] Cao R., Wang L., Wang H., Xia L., Erjument-Bromage H., Tempst P., Jones R.S., Zhang Y., Role of Histone H3 Lysine 27 methylation in Polycomb-Group silencing, Science, 298, pp. 1039-1043, (2002)
[5] Cardoso C., Mignon C., Hetet G., Grandchamps B., Fontes M., Colleaux I., The human EZH2 gene: Genomic organisation and revised mapping in 7q35 within a critical region of malignant disorders, Eur. J. Hum. Genet., 8, pp. 174-180, (2000)
[6] Czermin B., Melfi R., McCabe D., Seitz V., Imhof A., Pirotta V., Drosophila Enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal polycomb sites, Cell, 111, pp. 185-196, (2002)
[7] Dahiya A., Wong S., Gonzalo S., Gavin M., Dean D.C., Linking the Rb and polycomb pathways, Mol. Cell, 8, pp. 557-569, (2001)
[8] Dyson N., The regulation of E2F by pRB-family proteins, Genes Dev., 12, pp. 2245-2262, (1998)
[9] Frank S.R., Schroeder M., Fernandez P., Taubert S., Amati B., Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation, Genes Dev., 15, pp. 2069-2082, (2001)
[10] Fukuyama T., Otsuka T., Shigematsu H., Uchida N., Arima F., Ohno Y., Iwasaki H., Fukuda T., Niho Y., Proliferative involvement of ENX-1, a putative human Polycomb gene, in haematopoietic cells, Br. J. Haematol., 108, pp. 842-847, (2000)

← 1 2 3 4 5 →